Unique ID issued by UMIN | UMIN000024449 |
---|---|
Receipt number | R000028140 |
Scientific Title | Additional Effect of Perioperative, Compared with Preoperative, Immunonutrition After Pancreaticoduodenectomy: A Randomized, Controlled Trial |
Date of disclosure of the study information | 2016/10/18 |
Last modified on | 2020/03/20 14:05:25 |
Additional Effect of Perioperative, Compared with Preoperative, Immunonutrition After Pancreaticoduodenectomy: A Randomized, Controlled Trial
Additional Effect of Perioperative, Compared with Preoperative, Immunonutrition After Pancreaticoduodenectomy: A Randomized, Controlled Trial
Additional Effect of Perioperative, Compared with Preoperative, Immunonutrition After Pancreaticoduodenectomy: A Randomized, Controlled Trial
Additional Effect of Perioperative, Compared with Preoperative, Immunonutrition After Pancreaticoduodenectomy: A Randomized, Controlled Trial
Japan |
Pancreatic head cancer, distal cholangiocarcinoma, ampullary carcinoma, IPMN
Hepato-biliary-pancreatic surgery |
Malignancy
NO
The objective of present study is to evaluate whether perioperative, compared with preoperative, immunonutrition has additional effects on cell-mediated immunity and the infection rate after pancreaticoduodenectomy
Efficacy
Confirmatory
Phase IV
Postoperative Infectious Complication[ Time Frame: 30 days ]
Plasma IL-6, PGE2, CRP, Th1/Th2 Balance. [ Time Frame: 14 days ]
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
No treatment
2
Treatment
Medicine | Food |
Intervention
Dietary Supplement: Oral IMPACT
oral supplementation for 5 days (1L/day) before surgery and prolonged after surgery of a formula enriched with arginine, omega-3 fatty acids, and RNA. Other Name: Oral IMPACT; Ajinomoto Pharma Co., Ltd, Tokyo, Japan
Control
Dietary Supplement: Oral IMPACT
oral supplementation for 5 days (1L/day) before surgery of a formula enriched with arginine, omega-3 fatty acids, and RNA. Other Name: Oral IMPACT; Ajinomoto Pharma Co., Ltd, Tokyo, Japan
18 | years-old | <= |
Not applicable |
Male and Female
patients underwent pancreaticoduodenectomy
age younger than 18 years
ongoing infection
gastrointestinal obstruction
respiratory dysfunction
cardiac dysfunction
hepatic dysfunction
renal failure
history of recent immunosuppressive or immunological diseases
preoperative evidence of widespread metastatic disease
50
1st name | Katsunori |
Middle name | |
Last name | Furukawa |
Chiba University Graduate School of Medicine
Department of General Surgery
260-0856
1-8-1 Inohana, Chuo-ku, Chiba 260-0856, Japan.
043-226-2103
k-furukawa@umin.ac.jp
1st name | Katsunori |
Middle name | |
Last name | Furukawa |
Chiba University Graduate School of Medicine
Department of General Surgery
260-2856
1-8-1 Inohana, Chuo-ku, Chiba 260-0856, Japan.
043-226-2103
http://www.ho.chiba-u.ac.jp/5/
k-furukawa@umin.ac.jp
Department of General Surgery, Chiba University Graduate School of Medicine
Ministry of Education, Culture, Sports, Science and Technology.
Japanese Governmental office
Chiba University
1-8-1 Inohana, Chuo-ku, Chiba 260-0856, Japan.
043-226-2103
k-furukawa@umin.ac.jp
YES
NCT01969110
ClinicalTrials.gov
千葉大学医学部附属病院(千葉)
2016 | Year | 10 | Month | 18 | Day |
Published
https://www.ncbi.nlm.nih.gov/pubmed/30540966
71
Completed
2009 | Year | 02 | Month | 01 | Day |
2013 | Year | 01 | Month | 30 | Day |
2013 | Year | 02 | Month | 01 | Day |
2014 | Year | 08 | Month | 31 | Day |
2016 | Year | 10 | Month | 17 | Day |
2020 | Year | 03 | Month | 20 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028140
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |